A tutorial in genetic epidemiology and some considerations in statistical modeling.
Resumen Nuevas opciones han surgido para los profesionales de la salud desde que se anuncio en el 2003 que el genoma humano se habia completado, coincidiendo con el 50vo aniversario del descubrimiento de la estructura eliptica del ADN por Watson y Crick en 1953. La actualizacion continua...

Diagnostic molecular pathology, part 2: proteomics and clinical applications of molecular diagnostics in hematopathology.
Currently, molecular diagnostics plays an important role in the clinical management of a wide array of hematologic neoplasms, solid tumors, infectious diseases, and inherited genetic disorders. In this second part of our series, we conclude our review of esoteric techniques by summarizing some of the advances in the field...

Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Background & objectives: Paraoxonase (PON1), an arylesterase is associated with high density lipoprotein cholesterol (HDL-C). PON1 prevents low density lipo-protein cholesterol (LDL-C) from peroxidation and can also hydrolyze lipid peroxides, thereby providing protection against atherosclerosis and coronary artery disease (CAD). The incidence of CAD is known to be high...

Research and Markets Adds Report: Commercializing Molecular Diagnostics.
HEALTH AND BEAUTY CLOSE-UP-21 July 2008-Research and Markets Adds Report: Commercializing Molecular Diagnostics(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Research and Markets has announced the addition of the "Commercializing Molecular Diagnostics: Products, Services, Companies and Global Market" report to its offerings. In a release, Research and Markets...

High-Tech Entrepreneur Eric Greenberg Gives $1 Million To New York Presbyterian Hospital.
Eric Greenberg Genetic Research Investigator Grants to Provide Clinical Research of Pediatric Cardiology and Breast Cancer SAN FRANCISCO, and NEW YORK, Feb. 15 /PRNewswire/ -- Eric Greenberg, founder of Scient (Nasdaq: SCNT), Viant (Nasdaq: VIAN) and 12 Entrepreneuring, and the NewYork-Presbyterian -- the...

Luminex Corp. to Acquire Canadian Genetic Testing Company, Tm Bioscience.
SciTech21-15 December 2006-Luminex Corp. to Acquire Canadian Genetic Testing Company, Tm Bioscience(C)2006 JeraOne - http://www.jeraone.com Luminex Corporation will acquire Tm Bioscience Corporation, a Toronto-based commercial genetic testing company, in a stock exchange announced yesterday. Under the terms of the agreement, each Tm Bioscience share will...

The postgenomic era: implications for the clinical laboratory. (Advances in the Science of Pathology).
The cherry blossoms are truly cherry blossoms only while we wait. Kobayashi Issa (1) This issue of the Archives of Pathology & Laboratory Medicine features 11 papers presented at the Tenth Annual William Beaumont Hospital DNA Symposium, entitled "DNA Technology in the Clinical Laboratory," held...

The promise of gene therapy.
In recent years, research on gene therapy has yielded successes that offer much hope to patients suffering from a spectrum of diseases. I expect great advances, but researchers still face obstacles. One sign of the field's development is the growth of professional societies. The American Society of...

The promise of gene therapy.
In recent years, research on gene therapy has yielded successes that offer much hope to patients suffering from a spectrum of diseases. I expect great advances in the coming years, but researchers still face obstacles. One sign of the field's development is that funding for...

Virco and Tibotec to Merge.
Merger Will Combine Complementary Expertise in Drug Development and Pharmacogenomics MECHELEN, Belgium, Jan. 19 /PRNewswire/ -- The Boards of Directors of Virco Group NV and Tibotec Group NV announce that a merger proposal has been filed with the commercial court of Mechelen to...